Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer

Clinical trial NCT00786422 · COMPLETED

Trial details

NCT number: NCT00786422
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Venous Thrombosis Deep Vein Thrombosis

Start date: 2009-05-01
Primary completion: 2011-05-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.